Akari Therapeutics

查看带有其 12 名主要高管的组织结构图

Akari Therapeutics 搜索最多的简介

• Samir Patel, Chief Executive Officer
• Michael Grissinger, Director
• Sandip Patel, Director

高管在Akari Therapeutics变化

• Samir Patel 曾任 Interim Chief Executive Officer & Director, 现任 Chief Executive Officer  (新闻发布的2024十二月19号).
• Torsten Hombeck已作为Chief Financial Officer加入公司  (新闻发布的2024十二月18号).
• Wendy Dicicco, Interim Chief Financial Officer, 已经离开公司  (新闻发布的2024十二月18号).

创建提醒
跟踪 Akari Therapeutics 的高管变动

Akari Therapeutics 拥有 2,347 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• Bristol-Myers Squibb has announced the acquisition of 2Seventy Bio  (公布2025三月11号).
• Callio Therapeutics 刚刚宣布为 187 筹款数百万美元。 (公布2025三月7号).
• Eikon Therapeutics 刚刚宣布为 351 筹款数百万美元。 (公布2025二月27号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• VBI Vaccines 企业 Steven Gillis - Chairman of the Board
• UroGen 企业 Fred Cohen - Director

了解更多有关生物技术行业的信息 >

Akari Therapeutics 的最新新闻稿

• Akari Therapeutics Narrows Pipeline Focus | Akari Therapeutics
• Akari Therapeutics Announces Positive Results from Recent Pre-Clinical Studies of Investigational PASylated® Nomacopan That Support the Potential to Advance Research Toward IND/IMPD for Clinical Trials in Geographic Atrophy | Akari Therapeutics
• Press Releases | Akari Therapeutics
• Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress | Akari Therapeutics
• Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) | Akari Therapeuti
• Press Releases | Akari Therapeutics
• Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies | Akari Therapeutics
• Akari Therapeutics Presents Results from the CASCADE and CORONET Studies in COVID-19 at the American Thoracic Society (ATS) 2022 Annual Meeting | Akari Therapeutics
• Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical Progress | Akari Therapeutics
• Akari Therapeutics to Present Results from Compassionate Use of Nomacopan for COVID-19 (CORONET) and Identification of Clinical Deterioration Risk in COVID-19 (CASCADE) at the American Thoracic Society (ATS) 2022 Annual Meeting | Akari Therapeutics
• View more press releases Close

关于 Akari Therapeutics 的社交媒体

• Akari Therapeutics 在 维基百科、谷歌新闻 和 雅虎财经
• Akari Therapeutics 在 LinkedIn、叽叽喳喳 和 YouTube